Pseudohypoparathyroidism Type 1A with Normocalcaemia, due to the Novel C.389A>G Variant of Exon 5 of the Guanine Nucleotide-Binding Protein, α-Stimulating Gene
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pseudohypoparathyroidism type 1A (PHP1A) is a rare disease caused by molecular defects in the maternally-inherited allele of the guanine nucleotide-binding protein, α-stimulating (GNAS) gene. The GNAS gene encodes the stimulatory G-protein α-subunit that regulates production of the second messenger cyclic adenosine monophosphate. Heterozygous inactivating mutations in these specific loci are responsible for a spectrum of phenotypic characteristics of the disease, including clinical features of the Albright’s hereditary osteodystrophy, due to resistance to parathyroid hormone (PTH). We report a case of PHP1A and explore the underlying novel point mutation of the GNAS gene that leads to an atypical PHP1A phenotype. A male patient with a round face, short stature, and brachydactyly accompanied by normocalcaemia and mild PTH resistance consulted at our center. The GNAS encoding region from the patient and both of his parents were amplified and sequenced directly in a sample of peripheral blood leukocytes. A novel c.389A>G point mutation in exon 5 of the GNAS gene, resulting in a p.Tyr130Cys peptidic chain change of the Gsα protein, detected in the proband, in heterozygous state. Sequencing of the GNAS gene from his parents did not reveal the c.389A>G mutation, confirming a de novo proband genotype. The maternal origin of the affected GNAS allele, along with mild PTH resistance, confirmed the PHP1A diagnosis. PHP1A, caused by inactivating GNAS mutations, presents a range of complex clinical phenotypes. The novel c.389A>G GNAS mutation presented in this case expands the spectrum of known PHP1A molecular defects and describes the associated phenotype.
Abstract
Pseudohypoparathyroidism type 1A (PHP1A) is a rare disease caused by molecular defects in the maternally-inherited allele of the guanine nucleotide-binding protein, α-stimulating (GNAS) gene. The GNAS gene encodes the stimulatory G-protein α-subunit that regulates production of the second messenger cyclic adenosine monophosphate. Heterozygous inactivating mutations in these specific loci are responsible for a spectrum of phenotypic characteristics of the disease, including clinical features of the Albright’s hereditary osteodystrophy, due to resistance to parathyroid hormone (PTH). We report a case of PHP1A and explore the underlying novel point mutation of the GNAS gene that leads to an atypical PHP1A phenotype. A male patient with a round face, short stature, and brachydactyly accompanied by normocalcaemia and mild PTH resistance consulted at our center. The GNAS encoding region from the patient and both of his parents were amplified and sequenced directly in a sample of peripheral blood leukocytes. A novel c.389A>G point mutation in exon 5 of the GNAS gene, resulting in a p.Tyr130Cys peptidic chain change of the Gsα protein, detected in the proband, in heterozygous state. Sequencing of the GNAS gene from his parents did not reveal the c.389A>G mutation, confirming a de novo proband genotype. The maternal origin of the affected GNAS allele, along with mild PTH resistance, confirmed the PHP1A diagnosis. PHP1A, caused by inactivating GNAS mutations, presents a range of complex clinical phenotypes. The novel c.389A>G GNAS mutation presented in this case expands the spectrum of known PHP1A molecular defects and describes the associated phenotype.
참고문헌 (15)
- Albright F, "Pseudohypoparathyroidism: An example of “Seabright-Bantam sindrome", Endocrinology, 30, pp.922~932 (1942)
- Giovanna Mantovani, "Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement", Nature Reviews Endocrinology, 14(8), pp.476~500 (2018), Springer Science and Business Media LLC[DOI]
- Giovanna Mantovani, "Mutations in the Gs alpha gene causing hormone resistance", Best Practice & Research Clinical Endocrinology & Metabolism, 20(4), pp.501~513 (2006), Elsevier BV[DOI]
- Sue Richards, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genetics in Medicine, 17(5), pp.405~424 (2015), Elsevier BV[DOI]
- Susanne Thiele, "From pseudohypoparathyroidism to inactivating PTH", PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network, 2016, pp.175(6), P1~P17[DOI]
- Murat Bastepe, "Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo", Proceedings of the National Academy of Sciences, 101(41), pp.14794~14799 (2004), Proceedings of the National Academy of Sciences[DOI]
- Martin Munteanu, "Resistance to GHRH but Not to PTH in a 15-Year-Old Boy With Pseudohypoparathyroidism 1A", Journal of the Endocrine Society, 3(7), pp.1383~1389 (2019), The Endocrine Society[DOI]
- Inessa M. Gelfand, "Presentation and clinical progression of pseudohypoparathyroidism with multi-hormone resistance and Albright hereditary osteodystrophy: A case series", The Journal of Pediatrics, 149(6), pp.877~880 (2006), Elsevier BV[DOI]
- Xiao-dan Long, "Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia", BMC Medical Genetics, 19(1), pp.132~ (2018), Springer Science and Business Media LLC[DOI]
- N. Özbey, "Pseudohypoparathyroidism with normocalcemia", Journal of Endocrinological Investigation, 24(8), pp.642~643 (2001), Springer Science and Business Media LLC[DOI]
- Susanne Thiele, "A Disruptive Mutation in Exon 3 of the GNAS Gene with Albright Hereditary Osteodystrophy, Normocalcemic Pseudohypoparathyroidism, and Selective Long Transcript Variant Gsα-L Deficiency", The Journal of Clinical Endocrinology & Metabolism, 92(5), pp.1764~1768 (2007), The Endocrine Society[DOI]
- Yasuko TAMADA, "A Pseudohypoparathyroidism Type Ia Patient with Normocalcemia", Endocrine Journal, 55(1), pp.169~173 (2008), Japan Endocrine Society[DOI]
- Lee S. Weinstein, "Endocrine Manifestations of Stimulatory G Protein α-Subunit Mutations and the Role of Genomic Imprinting", Endocrine Reviews, 22(5), pp.675~705 (2001), The Endocrine Society[DOI]
- Manuel C. Lemos, "Pseudohypoparathyroidism type 1a due to a novel mutation in theGNASgene", Clinical Endocrinology, 84(3), pp.463~465 (2016), Wiley[DOI]
- Francesca Marta Elli, "The Prevalence of GNAS Deficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network", The Journal of Clinical Endocrinology & Metabolism, 101(10), pp.3657~3668 (2016), The Endocrine Society[DOI]